North Tide Capital is an investment fund managing more than $469 million ran by Stephen Shorey. There are currently 13 companies in Mr. Shorey’s portfolio. The largest investments include Select Med Hldgs Corp and Mckesson, together worth $163 million.
As of 9th February 2021, North Tide Capital’s top holding is 4,500,000 shares of Select Med Hldgs Corp currently worth over $86.4 million and making up 18.4% of the portfolio value.
In addition, the fund holds 500,000 shares of Mckesson worth $76.8 million, whose value fell approximately 0.1% in the past six months.
The third-largest holding is Supervalu Inc worth $43.5 million and the next is Mylan N V worth $42.4 million, with 1,350,000 shares owned.
Currently, North Tide Capital's portfolio is worth at least $469 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The North Tide Capital office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Stephen Shorey serves as the Chief Financial Officer at North Tide Capital.
In the most recent 13F filing, North Tide Capital revealed that it had opened a new position in Select Med Hldgs Corp and bought 4,500,000 shares worth $86.4 million.
The two most similar investment funds to North Tide Capital are Globeflex Capital L P and Crosslink Capital Inc. They manage $469 million and $469 million respectively.
North Tide Capital’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 44.7% of
the total portfolio value.
The fund focuses on investments in the United States as
46.2% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
23% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $35.1 billion.
These positions were updated on November 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Select Med Hldgs Corp |
Opened
4,500,000
|
$86,400,000 | 18.43% |
| Mckesson Corporation |
Opened
500,000
|
$76,805,000 | 16.38% |
| Supervalu Inc |
Opened
2,000,001
|
$43,500,000 | 9.28% |
| Mylan N V |
Opened
1,350,000
|
$42,350,000 | 9.03% |
| Gilead Sciences, Inc. |
Opened
500,000
|
$40,510,000 | 8.64% |
| Endo Intl Plc |
Opened
4,000,000
|
$34,260,000 | 7.31% |
| Tivity Health Inc |
Opened
750,000
|
$30,600,000 | 6.53% |
| Perrigo Co Plc |
Opened
300,000
|
$25,395,000 | 5.42% |
| Tenet Healthcare Corp. |
Opened
1,534,200
|
$25,207,000 | 5.38% |
| Express Scripts Hldg Co |
Opened
350,000
|
$22,162,000 | 4.73% |
| CVS Health Corp |
Opened
250,000
|
$20,330,000 | 4.34% |
| Invacare Corp. |
Opened
1,023,000
|
$16,112,000 | 3.44% |
| Pacific Biosciences Calif In |
Opened
1,000,000
|
$5,250,000 | 1.12% |
| No transactions found | |||
| Showing first 500 out of 13 holdings | |||